Pain outcomes: A brief review of instruments and techniques

Abstract

Pain is a difficult outcome to measure due to its multifaceted and subjective nature. The need for selecting proper outcome measures is high because of the increasing demand for scientifically valid demonstrations of treatment efficacy. This article discusses some basic topics in the measurement of pain outcomes and addresses issues such as statistical versus clinical significance, daily home data collection, appropriate length of outcome measurement packets, and the possibility of objective pain measurements. This article also reviews some of the more commonly used tools for measuring pain and pain-related disability. By selecting the proper tools and employing them correctly, we can obtain highly reliable and valid measures of pain outcomes in research and clinical care.

Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain: a systematic review

“…With regard to the pain construct, the authors of the present review recognise that the differences between pain intensity and pain severity are narrow. However, in order to facilitate the synthesis of results, we divided both constructs based on a previous literature review42 which showed that pain intensity is commonly measured with unidimensional instruments (eg, the numerical rating scale), whereas pain severity is mostly measured with multidimensional instruments (eg, the multidimensional pain inventory), where not only intensity of pain is taken into account. …”

A Comparative Analysis of Single Umbilical Tangential Incision vs. Conventional Three-port Totally Extraperitoneal Inguinal Hernia Repair

“…11 and pain scale is not completely accurate and reliable in assessing pain level. 12 Postoperative pain is related not only to the size of the incision but also to other several factors, such as extent of dissection, wound compression by instruments, variability of individual pain threshold, suture techniques, the operative time, and sensory nerve endings in the umbilicus skin etc. The relatively dense sensory innervation in the female umbilical skin was reported.…”

“Unsettling circularity”: Clinical trial enrichment and the evidentiary politics of chronic pain

“…The run-in or maintenance period used to identify drug responders typically involves titrating patients to a stable and tolerable dose that provides a mean improvement of 30 per cent or greater. About 30 per cent improvement has been proposed as the cutoff for a "clinically meaningful" response (Farrar et al, 2001;Younger et al, 2009), although this may vary from trial to trial (Farrar et al, 2001;Hewitt et al, 2011;Arthritis Research UK, 2013). So-called 'nonresponders' may include subjects who experience a lack of efficacy, fail to achieve a stabilized dose, or have too many or too serious adverse events, but patients may also be removed from the trial for protocol violation, withdrawal of consent, or other considerations (Hale et al, 2007;Katz et al, 2007;Hewitt et al, 2011).…”